| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/23/2002 | DE10055588A1 Konjugat, dessen Herstellung und Verwendung Conjugate, its preparation and use |
| 05/23/2002 | DE10055469A1 Konjugat, dessen Herstellung und Verwendung Conjugate, its preparation and use |
| 05/23/2002 | CA2856033A1 Use of a monoclonal antibody specific for a leukocyte to inhibit the reticuloendothelial system for the treatment of thrombocytopenia |
| 05/23/2002 | CA2429897A1 M. tuberculosis chaperonin 10 and uses thereof |
| 05/23/2002 | CA2429894A1 M. tuberculosis chaperonin 60.1 and uses thereof |
| 05/23/2002 | CA2429628A1 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 05/23/2002 | CA2429195A1 Immunoglobulin superfamily proteins |
| 05/23/2002 | CA2428863A1 Cysteine protease inhibitors |
| 05/23/2002 | CA2428748A1 Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants |
| 05/23/2002 | CA2428709A1 Association of calpain inhibitors and reactive oxygen species trapping agents |
| 05/23/2002 | CA2428707A1 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 05/23/2002 | CA2428527A1 (dihydro)isoquinoline derivatives as phosphodiesterase inhibitors |
| 05/23/2002 | CA2427902A1 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 05/23/2002 | CA2427900A1 Substituted 2-phenylaminoimidazoline phenyl ketone derivatives as ip antagonists |
| 05/22/2002 | EP1206935A1 Th2 differentiation inhibitors |
| 05/22/2002 | EP1206930A2 An oral treatment/care agent |
| 05/22/2002 | EP1206701A1 Antigenic components of selected indicator fungi and their use in methods and test kits |
| 05/22/2002 | EP1206573A1 26 human secreted proteins |
| 05/22/2002 | EP1206563A1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof |
| 05/22/2002 | EP1206553A2 Isomerase proteins |
| 05/22/2002 | EP1206543A2 Membrane associated proteins |
| 05/22/2002 | EP1206541A1 Dendritic enriched secreted lymphocyte activation molecule |
| 05/22/2002 | EP1206491A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
| 05/22/2002 | EP1206488A2 Method for isolating and purifying grass pollen allergens |
| 05/22/2002 | EP1206485A2 New effectors of dipeptidyl peptidase iv for topical use |
| 05/22/2002 | EP1206482A2 Method for coupling, in solution, a peptide with at least another compound and uses thereof |
| 05/22/2002 | EP1206480A2 Methods of obtaining 2-methoxyestradiol of high purity |
| 05/22/2002 | EP1206471A1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 05/22/2002 | EP1206467A1 N-heterocyclic derivatives as nos inhibitors |
| 05/22/2002 | EP1206458A1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 05/22/2002 | EP1206448A1 Novel vitamin d analogues |
| 05/22/2002 | EP1206444A1 Compounds that inhibit tryptase activity |
| 05/22/2002 | EP1206279A1 Method for treating tnf-receptor type-2-induced diseases |
| 05/22/2002 | EP1206265A1 Src kinase inhibitor compounds |
| 05/22/2002 | EP1206260A1 Src kinase inhibitor compounds |
| 05/22/2002 | EP1206254A1 Drug releasing biodegradable fiber implant |
| 05/22/2002 | EP1206233A2 Serine proteases |
| 05/22/2002 | EP1206190A1 Vaccines for the treatment of autoimmune disease |
| 05/22/2002 | EP1152776B1 Biodegradable, injectable oligomer-polymer composition |
| 05/22/2002 | EP1147107A4 Novel angiogenesis inhibitors |
| 05/22/2002 | EP0766676B1 Compounds for inhibiting phosphodiesterase iv |
| 05/22/2002 | EP0746329B1 Anti-inflammatory factor containing compositions, method of production, and use |
| 05/22/2002 | EP0583360B1 Compositions for the prevention and/or treatment of pathological processes |
| 05/22/2002 | CN1350547A Alleviation of the alelrgenic potential of airborne and contact allergens by thioredoxin |
| 05/22/2002 | CN1350539A Imidazo-containing heterocyclic compounds, their compositions and uses |
| 05/22/2002 | CN1350537A Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 05/22/2002 | CN1350536A 氨基甲酰基四氢吡啶衍生物 Carbamoyl tetrahydropyridine derivative |
| 05/22/2002 | CN1350534A Substituted bicyclic heteroaryl compounds as integrin antagonists |
| 05/22/2002 | CN1350520A Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds |
| 05/22/2002 | CN1350455A Use of combination of vitamins for the treatment of pruritus and relating to itching and/or non-infective inflammatory disorders |
| 05/22/2002 | CN1349825A Compound Chinese medicine prepn. containing Jisongrong and Its prepn process |
| 05/22/2002 | CN1349798A Blood pressure lowering and heart protecting tablet and its production process |
| 05/22/2002 | CN1085212C Rapamycin 42-oximes and hydroxylamines |
| 05/21/2002 | US6392053 Process for preparing arylacetylaminothiazoles |
| 05/21/2002 | US6392039 Coupling; salt formation |
| 05/21/2002 | US6392036 Sanitizing particles in sample; obtain sample, expose to heat, monitor sample for antiseptic nature |
| 05/21/2002 | US6392020 Monoclonal antibody to the clonotypic structure of a T-cell receptor, a pharmaceutical compostion and a diagnostic reagent comprising the same |
| 05/21/2002 | US6391909 Anandamide inhibitors as analgesic agents |
| 05/21/2002 | US6391908 Oxime amide indole type sPLA2 inhibitors |
| 05/21/2002 | US6391888 Topical anesthetics useful for treating cancer |
| 05/21/2002 | US6391887 3,4-Dihydroquinoline derivatives as nitrogen monoxide synthase (NOS) inhibitors |
| 05/21/2002 | US6391856 Method for treatment of allergic reaction using formyl peptide |
| 05/21/2002 | US6391581 DNA encoding interleukin-4 receptors |
| 05/21/2002 | US6391340 Dry powder pharmaceutical formulation |
| 05/21/2002 | US6391318 Composition comprising antigen and effective adjuvant amount of chitosan produced from chitin by deacetylation to degree of greater than 40% and having molecular weight between 10 kd and 500 kd |
| 05/21/2002 | US6391306 Treatment of infectious diseases with hsp90-peptide complexes |
| 05/21/2002 | CA2223245C Catechol diethers derivatives useful as pharmaceutical agents |
| 05/21/2002 | CA2215745C Human stat4 |
| 05/16/2002 | WO2002039117A1 Methods for the treatment of cellular proliferative disorders |
| 05/16/2002 | WO2002038744A2 Proteases |
| 05/16/2002 | WO2002038604A1 A new polypeptide-cicliary rootlet protein 45.98 and the polynucleotide encoding it |
| 05/16/2002 | WO2002038592A2 Peptides, the production and use thereof for binding immunoglobulins |
| 05/16/2002 | WO2002038575A1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase |
| 05/16/2002 | WO2002038563A2 Condensed pyrazindione derivatives as pde inhibitors |
| 05/16/2002 | WO2002038561A1 Indolylmaleimide derivatives as protein kinase c inhibitors |
| 05/16/2002 | WO2002038548A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 05/16/2002 | WO2002038547A1 Quinoline derivatives as nk-3 and nk-2 antagonists |
| 05/16/2002 | WO2002038541A1 Cyanopyrrolidine derivatives |
| 05/16/2002 | WO2002038177A2 Adjuvant combination formulations |
| 05/16/2002 | WO2002038176A2 Immunogenic compositions comprising liver stage malarial antigens |
| 05/16/2002 | WO2002038160A1 Method for the treatment of inflammation |
| 05/16/2002 | WO2002038146A1 Mucosal immunomodulator and use thereof |
| 05/16/2002 | WO2002038140A2 Therapeutic uses for ip3 receptor-mediated calcium channel modulators |
| 05/16/2002 | WO2002037937A2 Acid derivatives useful as serine protease inhibitors |
| 05/16/2002 | WO2002026727A3 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 05/16/2002 | WO2002019994A3 The treatment of inflammatory disorders |
| 05/16/2002 | WO2002010158A3 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 05/16/2002 | WO2002009681A3 A method for correcting the immune system of live body |
| 05/16/2002 | WO2002002640A3 Antibodies to human mcp-1 |
| 05/16/2002 | WO2002002090A3 Inhibitors of copper-containing amine oxidases |
| 05/16/2002 | WO2001098291A3 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 05/16/2002 | WO2001095890A3 Oral pharmaceutical compositions containing terbinafine |
| 05/16/2002 | WO2001087333A3 Immune system stimulating means |
| 05/16/2002 | WO2001083547A3 Anti-inflammatory compounds and uses thereof |
| 05/16/2002 | WO2001079843A3 Screening method for compounds |
| 05/16/2002 | WO2001079209A3 Diazafluorenone il-8 antagonists |
| 05/16/2002 | WO2001076638A3 Compositions for drug delivery |
| 05/16/2002 | WO2001075109A3 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability |
| 05/16/2002 | WO2001072292A3 Vitamin d compounds used to stabilize kidney transplants |
| 05/16/2002 | WO2001070663A3 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |